Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin
about
Low rates of sustained virologic response with peginterferon plus ribavirin for chronic hepatitis C virus infection in HIV infected patients in Rio de Janeiro, Brazil.CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core: Canadian guidelines for management and treatment of HIV/hepatitis C coinfection in adults.Haematological manifestations of human immune deficiency virus infection.The association of cytopenias and weight loss with hepatitis C virus virologic response in HIV/HCV-coinfected patients treated with PEG-IFN and RBV.
P2860
Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Randomized trial comparing dos ...... lated-interferon and ribavirin
@ast
Randomized trial comparing dos ...... lated-interferon and ribavirin
@en
type
label
Randomized trial comparing dos ...... lated-interferon and ribavirin
@ast
Randomized trial comparing dos ...... lated-interferon and ribavirin
@en
prefLabel
Randomized trial comparing dos ...... lated-interferon and ribavirin
@ast
Randomized trial comparing dos ...... lated-interferon and ribavirin
@en
P2093
P2860
P1476
Randomized trial comparing dos ...... lated-interferon and ribavirin
@en
P2093
Andrew H Talal
Barbara Johnston
Daniel Pearce
David Aboulafia
Hector Bonilla
Ira M Jacobson
Jeffrey Galpin
Jorge Rodriguez
Judy A Aberg
Leleka Doonquah
P2860
P304
P356
10.1097/QAI.0B013E3182324AF9
P407
P577
2011-11-01T00:00:00Z